Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Express Scripts
Covington
QuintilesIMS
Dow
Teva
Johnson and Johnson
Daiichi Sankyo

Generated: December 16, 2018

DrugPatentWatch Database Preview

ETHACRYNATE SODIUM Drug Profile

« Back to Dashboard

Summary for ETHACRYNATE SODIUM
Drug patent expirations by year for ETHACRYNATE SODIUM
Pharmacology for ETHACRYNATE SODIUM
Synonyms for ETHACRYNATE SODIUM
58-54-8 (Parent)
6500-81-8
Acetic acid, (2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy)-, sodium salt
AN-20071
C13H11Cl2O4.Na
CHEMBL1200487
D04079
D0W5UV
DTXSID10215320
Edecrin Sodium
Ethacrynate sodium (USP)
Ethacrynate sodium [USAN:USP]
Ethacrynate Sodium [USAN]
Ethacrynic acid sodium
K41MYV7MPM
LS-176418
OR067687
SCHEMBL42210
Sodium (2,3-dichloro-4-(2-methylenebutyryl)phenoxy)acetate
sodium 2-[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetate
SODIUM 2-[2,3-DICHLORO-4-(2-METHYLIDENEBUTANOYL)PHENOXY]ACETATE
Sodium edecrin
Sodium ethacrynate
UNII-K41MYV7MPM

US Patents and Regulatory Information for ETHACRYNATE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional ETHACRYNATE SODIUM ethacrynate sodium INJECTABLE;INJECTION 204634-001 Aug 23, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Sterile Products ETHACRYNATE SODIUM ethacrynate sodium INJECTABLE;INJECTION 205473-001 Jul 29, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Zydus Pharms Usa Inc ETHACRYNATE SODIUM ethacrynate sodium INJECTABLE;INJECTION 207758-001 Nov 17, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Express Scripts
Covington
QuintilesIMS
Dow
Teva
Johnson and Johnson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.